Cancer cachexia as a determinant of efficacy of first‑line pembrolizumab in patients with advanced non‑small cell lung cancer-Reference-Cited by-同舟云学术

Cancer cachexia as a determinant of efficacy of first‑line pembrolizumab in patients with advanced non‑small cell lung cancer

Published:2022-02-24 Issue:4 Volume:16 Page:
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:
Short-container-title:Mol Clin Oncol

Author:

Fujii Hironori¹,Araki Ayumu¹,Iihara Hirotoshi¹,Kaito Daizo²,Hirose Chiemi¹,Kinomura Motohiko¹,Yamazaki Mizuki¹,Endo Junki²,Inui Toshiya²,Yanase Komei²,Sasaki Yuka²,Gomyo Takenobu²,Sakai Chizuru²,Kawae Daisuke²,Kitamura Yu²,Fukui Masachika²,Kobayashi Ryo¹,Ohno Yasushi²,Suzuki Akio¹

Affiliation:

1. Department of Pharmacy, Gifu University Hospital, Gifu University Graduate School of Medicine, Gifu 501‑1194, Japan

2. Department of Cardiology and Respirology Medicine, Gifu University Graduate School of Medicine, Gifu 501‑1194, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference30 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): An open label, randomised phase 3 trial;Mitsudomi;Lancet Oncol,2010

3. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): A multicentre, open-label, randomised, phase 3 study;Zhou;Lancet Oncol,2011

4. Phase Ⅲ study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations;Sequist;J Clin Oncol,2013

5. First-line crizotinib versus chemotherapy in ALK-positive lung cancer;Solomon;N Engl J Med,2014

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progressive, multi‐organ, and multi‐layered nature of cancer cachexia;Cancer Science;2024-01-22

2. The role of pharmacists in multimodal cancer cachexia care;Asia-Pacific Journal of Oncology Nursing;2023-11

3. Low albumin status accompanies multi-layered immunosuppressive phenotypes in metastatic breast cancer patients;2023-09-07

4. Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors;Clinical & Translational Immunology;2023-01